Adolor Corporation
Adolor Corporation Reports Second Quarter 2009 Financial Results
Published in Healthcare Finance, Tax and Law Weekly, August 12th, 2009
Adolor Corporation (NasdaqGM: ADLR) reported net product sales of ENTEREG® (alvimopan) for the three and six months ended June 30, 2009 of approximately $2.4 million and $3.8 million, respectively, on total net shipments of approximately $2.9 million and $4.9 million, respectively. Under Adolor's current revenue recognition policy, revenue related to a customer shipment is deferred until subsequent re-orders by that customer. As of June 30, 2009, there were approximately 450 repeat-order hospitals for ENTEREG, up from 300 at March 31, 2009.
During the quarter, hospitals registered under the ENTEREG Access Support and Education (E.A.S.E.™) Program increased by...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
More Articles from Healthcare Finance, Tax and Law Weekly
- Abbott
Abbott and Medtronic Reach Agreement on Global Patent Disputes - ACG Cleveland
ACG Cleveland Announces Officers and Directors for 2009-2010 - ACS
ACS Appoints Connie Harvey Group President of Business Process Solutions - Aesyntix Health, Inc.
Aesyntix Physician Network Signs Exclusive Contract with Wholesale Merchant Group for Merchant Processing Services - Aetna
Aetna Adds WhiteGlove House Call Health to Austin Network - Aetna
Aetna Reports Second-Quarter 2009 Results - More from this issue of Healthcare Finance, Tax and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
